Greg M. Cole

Active 1985–2019

55
Papers
25,663
Citations
54
h-index
55
i10-index

Citations

Citations per year for Greg M. Cole1977: 1 citations1986: 2 citations1987: 2 citations1988: 6 citations1989: 25 citations1990: 19 citations1991: 18 citations1992: 36 citations1993: 26 citations1994: 48 citations1995: 31 citations1996: 34 citations1997: 90 citations1998: 105 citations1999: 122 citations2000: 162 citations2001: 208 citations2002: 242 citations2003: 202 citations2004: 269 citations2005: 263 citations2006: 305 citations2007: 307 citations2008: 390 citations2009: 381 citations2010: 483 citations2011: 359 citations2012: 355 citations2013: 268 citations2014: 310 citations2015: 289 citations2016: 343 citations2017: 351 citations2018: 303 citations2019: 889 citations2020: 890 citations2021: 883 citations2022: 742 citations2023: 553 citations2024: 722 citations2025: 403 citations2026: 12 citations1978–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,224 citing papers, 29.6% of this breakdownChina: 1,335 citing papers, 9.4% of this breakdownUnited Kingdom: 762 citing papers, 5.3% of this breakdownGermany: 679 citing papers, 4.8% of this breakdownItaly: 651 citing papers, 4.6% of this breakdownJapan: 493 citing papers, 3.5% of this breakdownCanada: 477 citing papers, 3.3% of this breakdownIndia: 475 citing papers, 3.3% of this breakdownAustralia: 400 citing papers, 2.8% of this breakdownSpain: 366 citing papers, 2.6% of this breakdownFrance: 350 citing papers, 2.5% of this breakdownSouth Korea: 330 citing papers, 2.3% of this breakdown
0%29.6%Other 26%

Fields

  • Medicine55.2%
  • Biochemistry, Genetics and Molecular Biology18.4%
  • Neuroscience17.7%
  • Nursing3.5%
  • Agricultural and Biological Sciences1.1%
  • Immunology and Microbiology1.1%
  • Other3%

Topics

  • Alzheimer's disease research and treatments18.9%
  • Neuroinflammation and Neurodegeneration Mechanisms8.2%
  • Cholinesterase and Neurodegenerative Diseases4.2%
  • Tryptophan and brain disorders3.4%
  • Computational Drug Discovery Methods3%
  • Neuroscience and Neuropharmacology Research2.7%
  • Other59.6%

Coauthors

All papers

Open in search
  1. Neuroinflammation in Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Olga Garaschuk, Erik Boddeke, Charles A. Dinarello, John C.S. Breitner, Greg M. Cole, Douglas T. Golenbock, Markus P. Kummer - The Lancet Neurology 2015 cited by 6,102

  2. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

    Authors: , , , , , , , - Science 1996 cited by 4,224

  3. Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

    Authors: , , , , , , , , , , , , , , , , , , - Alzheimer s Research & Therapy 2012 cited by 529

  4. The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse

    Authors: , , , , , - Journal of Neuroscience 2001 cited by 1,520

  5. -Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin

    Authors: , , , , , , , , , , , , - Journal of Neuroscience 2009 cited by 535

  6. Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis

    Authors: , , , , , , , , - Neurobiology of Disease 2019 cited by 126

  7. Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice

    Authors: , , , , , , , , , , , , - Journal of Biological Chemistry 2012 cited by 209

  8. NEUROPROTECTIVE EFFECTS OF CURCUMIN

    Authors: , , - Advances in experimental medicine and biology 2007 cited by 507

  9. Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer’s Disease

    Authors: , , , , , , , , , , , , , , - Journal of Pharmacology and Experimental Therapeutics 2008 cited by 601

  10. Microglial response to amyloid plaques in APPsw transgenic mice.

    Authors: , , , , , , - 1998 cited by 602

  11. A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model

    Authors: , , , , , , , , - Journal of Neuroscience 2005 cited by 682

  12. Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention

    Authors: , , , , , , , - Journal of Neuroscience 2004 cited by 324

  13. Clinical development of curcumin in neurodegenerative disease

    Authors: , , , , , , - Expert Review of Neurotherapeutics 2015 cited by 179

  14. Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease

    Authors: , , , , , , , , , , - Journal of Neuroscience 2000 cited by 880

  15. Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model

    Authors: , , , , , , , , , , , - Neuron 2004 cited by 707

  16. Omega-3 fatty acids and dementia

    Authors: , , - Prostaglandins Leukotrienes and Essential Fatty Acids 2009 cited by 260

  17. Cyclooxygenase-2 inhibition improves amyloid-β-mediated suppression of memory and synaptic plasticity

    Authors: , , , , , , , , , , , , , , , , , - Brain 2008 cited by 220

  18. PET of Brain Amyloid and Tau in Mild Cognitive Impairment

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2006 cited by 735

  19. Nutrition, Brain Aging, and Neurodegeneration: Table 1.

    Authors: , , , - Journal of Neuroscience 2009 cited by 262

  20. GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals

    Authors: , , , , , , , , , , , , , - Neurobiology of Disease 2008 cited by 172

  21. Loss of MAP Function Leads to Hippocampal Synapse Loss and Deficits in the Morris Water Maze with Aging

    Authors: , , , , , , , , , , , , , - Journal of Neuroscience 2014 cited by 134

  22. Vitamin E protects nerve cells from amyloid βprotein toxicity

    Authors: , , , - Biochemical and Biophysical Research Communications 1992 cited by 582

  23. Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: Evidence from animal studies

    Authors: , - Prostaglandins Leukotrienes and Essential Fatty Acids 2007 cited by 291

  24. Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease

    Authors: , , , , , , , , , , , , , - Nature Neuroscience 2006 cited by 309